{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:37:06Z","timestamp":1792791426748,"version":"4.5.0"},"reference-count":18,"publisher":"Scientific Scholar","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Dermatol Venereol Leprol"],"published-print":{"date-parts":[[2016]]},"DOI":"10.4103\/0378-6323.174379","type":"journal-article","created":{"date-parts":[[2016,1,19]],"date-time":"2016-01-19T09:12:41Z","timestamp":1453194761000},"page":"389","source":"Crossref","is-referenced-by-count":38,"title":["Clinical efficacy of rituximab in the treatment of pemphigus: A retrospective study"],"prefix":"10.25259","volume":"82","author":[{"given":"VinodKumar","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neetu","family":"Bhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somesh","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanika","family":"Sahni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neena","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Ramam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Sethuraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","reference":[{"key":"key-10.4103\/0378-6323.174379-1","first-page":"439","volume-title":"Pemphigus in India","author":"Kanwar","year":"2011","journal-title":"Indian J Dermatol Venereol Leprol","ISSN":"https:\/\/id.crossref.org\/issn\/0378-6323","issn-type":"print"},{"key":"key-10.4103\/0378-6323.174379-2","first-page":"875","volume-title":"Dexamethasone-cyclophosphamide pulse therapy for pemphigus","author":"Pasricha","year":"1995","journal-title":"Int J Dermatol"},{"key":"key-10.4103\/0378-6323.174379-3","first-page":"785","volume-title":"Anti-CD20 chimeric monoclonal antibody (rituximab) for the treatment of recalcitrant, life-threatening pemphigus vulgaris with implications in the pathogenesis of the disorder","author":"Salopek","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0378-6323.174379-4","first-page":"142","volume-title":"Successful treatment of paraneoplastic pemphigus in follicular NHL with rituximab: Report of a case and review of treatment for paraneoplastic pemphigus in NHL and CLL","author":"Heizmann","year":"2001","journal-title":"Am J Hematol"},{"key":"key-10.4103\/0378-6323.174379-5","first-page":"1043","volume-title":"Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus","author":"Murrell","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0378-6323.174379-6","first-page":"545","volume-title":"A single cycle of rituximab for the treatment of severe pemphigus","author":"Joly","year":"2007","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0378-6323.174379-7","first-page":"617","volume-title":"Therapy with rituximab for autoimmune pemphigus: Results from a single-center observational study on 42 cases with long-term follow-up","author":"Cianchini","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0378-6323.174379-8","first-page":"646","volume-title":"Clinical efficacy of different doses of rituximab in the treatment of pemphigus: A retrospective study of 27 patients","author":"Kim","year":"2011","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0378-6323.174379-9","first-page":"186","volume-title":"Clinical experiences of different dosing schedules of rituximab in pemphigus with various disease severities","author":"Cho","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key-10.4103\/0378-6323.174379-10","first-page":"703","volume-title":"Durable remission of pemphigus with a fixed-dose rituximab protocol","author":"Heelan","year":"2014","journal-title":"JAMA Dermatol"},{"key":"key-10.4103\/0378-6323.174379-11","first-page":"300","volume-title":"Intermediate doses of rituximab used as adjuvant therapy in refractory pemphigus","author":"Londhe","year":"2014","journal-title":"Indian J Dermatol Venereol Leprol","ISSN":"https:\/\/id.crossref.org\/issn\/0378-6323","issn-type":"print"},{"key":"key-10.4103\/0378-6323.174379-12","first-page":"1031","volume-title":"Adjuvant rituximab therapy of pemphigus: A single-center experience with 31 patients","author":"Lunardon","year":"2012","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/0378-6323.174379-13","first-page":"404","volume-title":"Successful treatment of pemphigus with biweekly 1-g infusions of rituximab: A retrospective study of 47 patients","author":"Leshem","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0378-6323.174379-14","first-page":"1341","volume-title":"Clinical and immunological outcomes of high- and low-dose rituximab treatments in patients with pemphigus: A randomized, comparative, observer-blinded study","author":"Kanwar","year":"2014","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0378-6323.174379-15","first-page":"17","volume-title":"Rituximab in the treatment of pemphigus vulgaris","author":"Zakka","year":"2012","journal-title":"Dermatol Ther (Heidelb)"},{"key":"key-10.4103\/0378-6323.174379-16","first-page":"777","volume-title":"An assessment of treatment history and its association with clinical outcomes and relapse in 155 pemphigus patients with response to a single cycle of rituximab","author":"Amber","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key-10.4103\/0378-6323.174379-17","first-page":"622","volume-title":"Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris","author":"Chams-Davatchi","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0378-6323.174379-18","first-page":"659","volume-title":"Evaluation of cyclophosphamide pulse therapy as an adjuvant to oral corticosteroid in the management of pemphigus vulgaris","author":"Sharma","year":"2013","journal-title":"Clin Exp Dermatol"}],"container-title":["Indian Journal of Dermatology, Venereology, and Leprology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T10:45:15Z","timestamp":1611917115000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijdvl.com\/clinical-efficacy-of-rituximab-in-the-treatment-of-pemphigus-a-retrospective-study\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016]]}},"alternative-id":["174379"],"URL":"https:\/\/doi.org\/10.4103\/0378-6323.174379","relation":{},"ISSN":["0378-6323"],"issn-type":[{"value":"0378-6323","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}